Assessment of Cognitive Function and Functional Performance in Patients With Type 2 Diabetes
NCT07390292 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2026-02-05
Summary
Diabetes is a chronic metabolic disease that is becoming a growing public health problem worldwide, affecting people's lives in many ways. It is characterized by impaired carbohydrate, lipid, and protein metabolism associated with insufficient insulin secretion and/or reduced sensitivity to the metabolic effects of insulin.Along with diabetes, many complications may develop in affected individuals. Cognitive impairments are now also considered an important and common complication of diabetes.The aim of this study is to investigate the effects of cognitive function levels on functional capacity, balance, fear of falling, and quality of life in individuals with type 2 diabetes.In this context, participants' cognitive function levels will be assessed using the Mini-Mental State Examination and the Stroop Test. Functional capacity will be evaluated using the 6-Minute Walk Test. Balance performance will be assessed using the Biodex Balance System and the Four Square Step Test. Lower extremity muscle strength will be measured using a digital hand-held dynamometer and the 30-Second Sit-to-Stand Test. Fear of falling will be evaluated using the Falls Efficacy Scale-International (FES-I), the Functional Reach Test, and the Timed Up and Go (TUG) Test. Participants' quality of life will be assessed using the WHOQOL-BREF quality of life questionnaire.
Conditions
Interventions
- OTHER
-
No intervention (observational study)
This is an observational study. No treatment was applied to the individuals. The study will evaluate the individuals' cognitive functions and functional capacities, balance, fear of falling, and quality of life.
Sponsors & Collaborators
-
Bezmialem Vakif University
lead OTHER
Eligibility
- Min Age
- 40 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-02-28
- Primary Completion
- 2026-04-30
- Completion
- 2026-05-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Evaluation and Intervention of Cognitive Function in Patients With Diabetes Mellitus.
NCT05262257 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Effect of SGLT2 Inhibitors on Cognitive Functions and BDNF Levels in Patients With Type 2 Diabetes
NCT05341388 ·Status: TERMINATED
-
Early Detection of Cognitive Dysfunction in Diabetes
NCT01830998 ·Status: UNKNOWN
-
Prediabetes and Type 2 Diabetes in Aging
NCT06953609 ·Status: COMPLETED
-
Diabetes and Cognitive Functions in Middle Age
NCT05919927 ·Status: UNKNOWN
-
The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus
NCT07128186 ·Status: RECRUITING
-
Investigating the Insulin Resistance in Individuals With Type 2 Diabetes
NCT06428968 ·Status: RECRUITING ·Phase: NA
-
The Association Between Cognitive Function and Neuropathy in Individuals With Type 2 Diabetes
NCT06857994 ·Status: COMPLETED
-
Effectiveness of a Virtual Health Management Community (VHMC) for Pre-diabetes in China
NCT07338552 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Utilizing Glycaemic Index: An Investigation of the Glycaemia and Cognition in Type 2 Diabetes
NCT03360604 ·Status: COMPLETED ·Phase: NA
-
Risk Factors for Type 2 Diabetes Mellitus With Cognitive Impairment: a Cohort Study
NCT05728567 ·Status: ACTIVE_NOT_RECRUITING
-
Cognitive Screening and Multidomain Intervention Targeting Cognitive Decline in Type 2 Diabetes (The Brain Care Study)
NCT07250789 ·Status: RECRUITING ·Phase: NA
-
Conditions Associated With Poorly Controlled Diabetes in Patients With Type 2 Diabetes and HbA1c Changes With Therapy
NCT05394571 ·Status: COMPLETED
-
Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
NCT03707171 ·Status: COMPLETED ·Phase: PHASE3
-
Carotid Body Function in Type 2 Diabetes Mellitus
NCT05237076 ·Status: COMPLETED ·Phase: NA
-
China Diabetes Cognitive Dysfunction Early Diagnosis and Intervention Study (China-DECODE Study)
NCT06650969 ·Status: RECRUITING
-
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings
NCT02322762 ·Status: COMPLETED
-
Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control in T2DM
NCT04438018 ·Status: COMPLETED
-
Risk Model of Cognitive Impairment in Diabetes
NCT05590442 ·Status: RECRUITING
-
Insulin Sensitivity of the Brain in Pathogenesis of Diabetes Mellitus Type 2
NCT00638209 ·Status: UNKNOWN ·Phase: NA
-
Changes in Hematological Parameters With Glycemia Control in Type 2 Diabetes
NCT06228898 ·Status: COMPLETED
-
Characteristics of Papez Loop Neural Network in T2DM (Type 2 Diabetes Mellitus)
NCT06912321 ·Status: RECRUITING
-
Developement of Questionnaire to Evaluate a Regularity of Lifestyle in Type 2 Diabetic Patients
NCT00455988 ·Status: UNKNOWN
-
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
NCT05313529 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients
NCT07244770 ·Status: RECRUITING